无肌肉骨骼症状的银屑病患者队列的临床与超声特征:一项前瞻性多中心研究
前瞻性多中心研究纳入78例无肌肉骨骼症状且未接受系统治疗的银屑病患者,基线及随访时由风湿科医生采集临床与超声数据。中位随访76.60个月后,34例(56.6%)出现肌肉骨骼症状,5例(8.3%)出现炎症性症状,4例符合CASPAR标准(5.5%);附着点超声滑囊炎与提示银屑病关节炎的症状出现相关。
要点
- 无肌肉骨骼症状的轻度银屑病患者银屑病关节炎年发病率约为1%。
- 基线附着点超声滑囊炎与提示银屑病关节炎的症状出现相关(P=0.049)。
- 出现肌肉骨骼症状者基线BMI、腹围、疼痛及疲劳评分更高,超声总分更高。
核心结论
- 在轻度、未接受系统治疗且无肌肉骨骼症状的银屑病患者队列中,银屑病关节炎年发病率约为1%。
- 附着点超声滑囊炎与提示银屑病关节炎的症状出现相关。
- 出现肌肉骨骼症状的患者基线BMI、疲劳和疼痛视觉模拟评分更高,可能构成向银屑病关节炎转变风险更高的亚组。
研究设计与样本
- 前瞻性多中心研究,纳入由皮肤科医生随访的银屑病患者,基线及随访期间由风湿科医生采集临床与超声数据。
- 共纳入78例银屑病患者,其中60例完成研究。
主要发现
- 患者平均病程15.1年(标准差±13.4),82%为轻度银屑病,36例(39.7%)有甲病变,38例(48.7%)超重或肥胖。
- 超声评估中,9例(11.5%)关节能量多普勒1级,56.4%附着点有钙化,30.4%附着点有滑囊炎。
- 中位随访76.60个月(四分位距39.34-85.25)后,34例(56.6%)出现肌肉骨骼症状,其BMI更高(P=0.013)、腹围更大(P=0.022)、疼痛评分更高(P=0.047)、疲劳评分更高(P=0.011),基线超声总分更高(P=0.037)。
- 5例(8.3%)出现肌肉骨骼炎症症状,4例符合CASPAR标准(5.5%);从基线至银屑病关节炎诊断的平均时间为20.20个月(标准差±12.02)。
- 出现炎症症状的患者中80%存在超声滑囊炎(P=0.049)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate clinical and ultrasound (US) features related to psoriatic arthritis (PsA) development in psoriasis (PsO), patients without musculoskeletal (MSK) symptoms and no systemic treatment. METHODS: Prospective study including PsO patients followed by dermatologists. Clinical and US data were collected at baseline and during follow-up by rheumatologists. RESULTS: Seventy-eight patients with PsO were included. Mean disease duration was 15.1 years (SD ± 13.4); most had mild PsO (82%), onychopathy was present in 36 (39.7%) and overweight/obesity in 38 patients (48.7%). In the US evaluation, nine patients (11.5%) had Power Doppler grade 1 at joints, 56.4% had calcifications and 30.4% bursitis at enthesis. Sixty patients completed the study. After a median of 76.60 months (IQR 39.34-85.25), 34 patients (56.6%) developed MSK symptoms. They had higher BMI (P = 0.013), abdominal circumference (P = 0.022), scored higher for pain (P = 0.047) and fatigue (P = 0.011). Their baseline US showed a higher total US score (P = 0.037). Five patients (8.3%) developed MSK inflammatory symptoms, and four met CASPAR criteria (5.5%). The mean time from baseline to PsA diagnosis was 20.20 months (SD ± 12.02). US bursitis was present in 80% of patients developing inflammatory symptoms (P = 0.049). CONCLUSIONS: In a cohort of patients with mild PsO, systemic therapy-naive and no MSK symptoms, incidence of PsA was 1% per year. US bursitis at enthesis was related to the development of symptoms suggestive of PsA. Patients who developed MSK symptoms had higher BMI, fatigue and pain VAS scores at baseline and could constitute a subgroup with higher risk for transition to PsA.
引用
- Azuaga AB, Cuervo A, Reina D, et al. Clinical and ultrasound features of a cohort of psoriasis patients without musculoskeletal symptoms: a prospective and multicentre study. Rheumatology (Oxford). 2025. PMID: 40465417. doi:10.1093/rheumatology/keaf307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。